HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $7.83 billion. The enterprise value is $8.55 billion.
| Market Cap | 7.83B |
| Enterprise Value | 8.55B |
Important Dates
The last earnings date was Wednesday, December 3, 2025, after market close.
| Earnings Date | Dec 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 85.44 million shares outstanding. The number of shares has decreased by -0.34% in one year.
| Current Share Class | 85.44M |
| Shares Outstanding | 85.44M |
| Shares Change (YoY) | -0.34% |
| Shares Change (QoQ) | -0.88% |
| Owned by Insiders (%) | 1.84% |
| Owned by Institutions (%) | 106.01% |
| Float | 83.82M |
Valuation Ratios
The trailing PE ratio is 42.10 and the forward PE ratio is 21.12. HealthEquity's PEG ratio is 1.01.
| PE Ratio | 42.10 |
| Forward PE | 21.12 |
| PS Ratio | 6.14 |
| Forward PS | 5.63 |
| PB Ratio | 3.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.95 |
| P/OCF Ratio | 18.86 |
| PEG Ratio | 1.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.80, with an EV/FCF ratio of 20.69.
| EV / Earnings | 44.55 |
| EV / Sales | 6.62 |
| EV / EBITDA | 18.80 |
| EV / EBIT | 28.54 |
| EV / FCF | 20.69 |
Financial Position
The company has a current ratio of 4.13, with a Debt / Equity ratio of 0.48.
| Current Ratio | 4.13 |
| Quick Ratio | 3.49 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 2.24 |
| Debt / FCF | 2.49 |
| Interest Coverage | 5.06 |
Financial Efficiency
Return on equity (ROE) is 9.01% and return on invested capital (ROIC) is 5.83%.
| Return on Equity (ROE) | 9.01% |
| Return on Assets (ROA) | 5.43% |
| Return on Invested Capital (ROIC) | 5.83% |
| Return on Capital Employed (ROCE) | 9.14% |
| Revenue Per Employee | $413,673 |
| Profits Per Employee | $61,483 |
| Employee Count | 3,120 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $54.67 million in taxes.
| Income Tax | 54.67M |
| Effective Tax Rate | 22.18% |
Stock Price Statistics
The stock price has decreased by -5.40% in the last 52 weeks. The beta is 0.18, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -5.40% |
| 50-Day Moving Average | 97.02 |
| 200-Day Moving Average | 94.58 |
| Relative Strength Index (RSI) | 36.51 |
| Average Volume (20 Days) | 877,273 |
Short Selling Information
The latest short interest is 4.66 million, so 5.45% of the outstanding shares have been sold short.
| Short Interest | 4.66M |
| Short Previous Month | 4.35M |
| Short % of Shares Out | 5.45% |
| Short % of Float | 5.55% |
| Short Ratio (days to cover) | 4.83 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.29 billion and earned $191.83 million in profits. Earnings per share was $2.18.
| Revenue | 1.29B |
| Gross Profit | 874.01M |
| Operating Income | 299.41M |
| Pretax Income | 246.49M |
| Net Income | 191.83M |
| EBITDA | 454.57M |
| EBIT | 299.41M |
| Earnings Per Share (EPS) | $2.18 |
Balance Sheet
The company has $309.26 million in cash and $1.03 billion in debt, giving a net cash position of -$719.01 million or -$8.42 per share.
| Cash & Cash Equivalents | 309.26M |
| Total Debt | 1.03B |
| Net Cash | -719.01M |
| Net Cash Per Share | -$8.42 |
| Equity (Book Value) | 2.13B |
| Book Value Per Share | 24.93 |
| Working Capital | 378.08M |
Cash Flow
In the last 12 months, operating cash flow was $414.93 million and capital expenditures -$1.97 million, giving a free cash flow of $412.96 million.
| Operating Cash Flow | 414.93M |
| Capital Expenditures | -1.97M |
| Free Cash Flow | 412.96M |
| FCF Per Share | $4.83 |
Margins
Gross margin is 67.72%, with operating and profit margins of 23.20% and 14.86%.
| Gross Margin | 67.72% |
| Operating Margin | 23.20% |
| Pretax Margin | 19.10% |
| Profit Margin | 14.86% |
| EBITDA Margin | 35.22% |
| EBIT Margin | 23.20% |
| FCF Margin | 32.00% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.34% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 2.45% |
| FCF Yield | 5.28% |
Analyst Forecast
The average price target for HealthEquity is $119.07, which is 29.98% higher than the current price. The consensus rating is "Buy".
| Price Target | $119.07 |
| Price Target Difference | 29.98% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.87 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.87 |
| Piotroski F-Score | 8 |